WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today announced that over 40 abstracts, detailing studies conducted by Incyte, Novartis and multiple independent investigators in patients with myeloproliferative neoplasms (MPNs), will be presented at the 50th Annual Meeting of the American Society of Hematology (ASH), which is to be held from December 6-9, 2014 in San Francisco.
Help employers find you! Check out all the jobs and post your resume.
